This review provides an overview of established and experimental antiplatelet therapies targeting different stages of thrombus formation.
No takes yet. Share an insight, caveat, or question.
Should not change antiplatelet prescribing; leaves open validation of experimental targets in trials.
Meyer et al. (2008) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: